44927-2 |
Prolactin^30M post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
44927-2 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 30M p TRH IV SerPl-aCnc |
|
|
|
N |
|
30M p TRH; 30M p TRH IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
44928-0 |
Prolactin^15M pre dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
44928-0 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 15M pre TRH IV SerPl-aCnc |
|
|
|
N |
|
15M pre TRH; 15M pre TRH IV; Arbitrary Concentration; Before; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Pl; Plasma; Plsm; Point in time; pre TRH; pre TRH IV; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
44929-8 |
Prolactin^15M post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
44929-8 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 15M p TRH IV SerPl-aCnc |
|
|
|
N |
|
15m p TRH; 15M p TRH IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
4493-3 |
Complement C3d+G |
ACnc |
Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Complement C3d+G [Units/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
4493-3 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated C3d+G Plas-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44930-6 |
Prolactin^2H post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --2 hours post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
44930-6 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 2h p TRH IV SerPl-aCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p TRH; 2h p TRH IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
44931-4 |
Prolactin^pre dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --pre dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
44931-4 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin pre TRH IV SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Pl; Plasma; Plsm; Point in time; pre TRH; pre TRH IV; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
44932-2 |
Protein.monoclonal band 2/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 2/Protein.total in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
44932-2 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 2 MFr SerPl Elph |
|
|
|
N |
|
Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; II; M Protein; M Protein 2; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.73 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
44933-0 |
Observation |
SpGrav |
Urine |
24H |
Qn |
Refractometry |
|
ACTIVE |
Specific gravity of 24 hour Urine by Refractometry |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44933-0 |
|
Refractometry |
|
|
Both |
|
|
|
0 |
Sp Gr 24h Ur Refractometry |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; Refract; Sp Gr; UA; UR; Urn |
2.79 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
44934-8 |
Thymidine kinase |
CCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Thymidine kinase [Enzymatic activity/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
44934-8 |
|
|
|
|
Both |
|
|
|
0 |
Thymidine kinase Ser-cCnc |
|
|
|
N |
|
Catalytic Concentration; Chemistry; Deoxythymidine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; TK |
2.73 |
2.17 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
44935-5 |
Thyrotropin^15M post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
44935-5 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 15M p TRH IV SerPl-aCnc |
|
|
|
N |
|
15m p TRH; 15M p TRH IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.73 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
44936-3 |
Thyrotropin^15M pre dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
44936-3 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 15M pre TRH IV SerPl-aCnc |
|
|
|
N |
|
15M pre TRH; 15M pre TRH IV; Arbitrary Concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Pl; Plasma; Plsm; Point in time; pre TRH; pre TRH IV; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
44937-1 |
Thyrotropin^pre dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
44937-1 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated TSH pre TRH IV SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Pl; Plasma; Plsm; Point in time; pre TRH; pre TRH IV; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.7 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44938-9 |
Hepatitis D virus Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44938-9 |
|
IA |
|
|
Both |
|
|
|
0 |
HDV IgM Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Delta hepatitis; Dextro; EIA; ELFA; ELISA; Enzyme immunoassay; HDV; HDVAB; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
44939-7 |
Adverse drug reaction |
Hx |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
History of Adverse drug reaction Narrative |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
44939-7 |
|
|
|
|
Observation |
|
|
|
0 |
Hx of Adverse drug rxn |
|
|
|
N |
|
Adverse drug rxn; Drugs; H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; React; Report; Rxn |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Changed Component from "History of adverse drug reaction" to "Adverse drug reaction" and Property from "Find" to "Hx" per 8/2015 Clinical LOINC Committee decision |
0 |
4494-1 |
Complement C3d+G |
MCnc |
Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Complement C3d+G [Mass/volume] in Plasma |
|
DEL |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
HEM/BC |
|
4494-1 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated C3d+G Plas-mCnc |
|
|
|
Y |
|
Comp; Complmt; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.65 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44940-5 |
Alcoholic drinks per W |
NRat |
^Patient |
1W |
Qn |
Reported |
|
ACTIVE |
Alcoholic drinks per week - Reported |
|
MIN |
DefinitionDescription |
|
|
#/week |
|
|
|
|
|
|
H&P.HX |
|
44940-5 |
|
Reported |
|
|
Observation |
|
|
|
0 |
Alcoholic drinks per W Reported |
|
|
|
N |
|
1 week; Count/time; H+P; H+P.HX; nRate; Number rate; Number Rate = Count/Time; P prime; QNT; Quan; Quant; Quantitative |
2.48 |
2.17 |
|
|
|
|
|
|
|
{#}/wk |
|
|
|
0 |
44941-3 |
Barriers to self management |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Barriers to self management |
|
MIN |
DefinitionDescription |
|
|
|
Has very limited vision and therefore cannot administer his own insulin |
|
|
|
|
|
H&P.HX |
|
44941-3 |
|
|
|
|
Observation |
|
|
|
0 |
Barriers to self management |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44942-1 |
First nations living status |
Find |
^Family |
Pt |
Ord |
|
|
ACTIVE |
First nations living status from Family |
|
MIN |
DefinitionDescription |
|
|
|
Yes, individual lives on an Indian reserve; No, individual does not live on an Indian reserve. |
|
|
|
|
|
H&P.HX |
|
44942-1 |
|
|
|
|
Observation |
|
|
|
0 |
Family First nations living status |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.29 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44943-9 |
Self management |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Self management |
|
MIN |
DefinitionDescription |
|
|
|
Yes |
|
|
|
|
|
DOC.MISC |
|
44943-9 |
|
|
|
|
Observation |
|
|
|
0 |
Self management |
|
|
|
N |
|
DOC.MISC; Finding; Findings; MISC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44944-7 |
Other alert |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Other alert |
|
MIN |
DefinitionDescription |
|
|
|
Has episodes of frequent hypoglycemia. |
|
|
|
|
|
H&P.HX |
|
44944-7 |
|
|
|
|
Observation |
|
|
|
0 |
Other alert |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Nominal; Othr; P prime; Point in time; Random |
2.46 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44945-4 |
Australian cervix cytology code |
Imp |
XXX |
Pt |
Nom |
|
|
ACTIVE |
Australian cervix cytology code [Interpretation] of Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CYTO |
|
44945-4 |
|
|
|
|
Observation |
|
|
|
0 |
AUSCvxCyt Spec-Imp |
|
|
|
N |
|
AUSCvxCyt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.69 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44946-2 |
Borrelia burgdorferi 31kD Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Borrelia burgdorferi 31kD IgG Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44946-2 |
|
IB |
|
|
Observation |
|
|
|
0 |
B burgdor31kD IgG Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor31kD; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; OSP A; OSPA; Outer surface protein A; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
44947-0 |
Borrelia burgdorferi 31kD Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Borrelia burgdorferi 31kD IgM Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44947-0 |
|
IB |
|
|
Observation |
|
|
|
0 |
B burgdor31kD IgM Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor31kD; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; OSP A; OSPA; Outer surface protein A; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
44948-8 |
Borrelia burgdorferi 34kD Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Borrelia burgdorferi 34kD IgM Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44948-8 |
|
IB |
|
|
Observation |
|
|
|
0 |
B burgdor34kD IgM Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor34kD; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; OSP B; OSPB; Outer surface protein B; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
44949-6 |
Borrelia burgdorferi 34kD Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Borrelia burgdorferi 34kD IgG Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44949-6 |
|
IB |
|
|
Observation |
|
|
|
0 |
B burgdor34kD IgG Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor34kD; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; OSP B; OSPB; Outer surface protein B; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |